Literature DB >> 16631446

Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test.

Ikram Aloulou1, Jean-Frederic Brun, Jacques Mercier.   

Abstract

There is a need for reliable measurements of insulin sensitivity (SI) simpler than the euglycemic hyperinsulinemic clamp or the intravenous glucose tolerance test (IVGTT), which could be used when the simpler surrogates based on fasting insulin (Ib) and glucose (Gb) lose their validity. Several evaluations of SI derived from oral glucose tolerance test (OGTT) or its physiologic form, the standardized breakfast test (SBT), have been proposed. We aimed at determining which SBT-derived measurements of SI give the best prediction of the values obtained with the minimal model analysis of an IVGTT. Twenty-eight subjects (23 females and 5 males; age, 44.3+/-0.6 years) with a wide range of glucose tolerance randomly underwent a hyperglucidic SBT and an IVGTT with minimal model analysis. Correlations of 35 indices (converted if appropriated into similar units) with IVGTT-derived SI were calculated, and the accuracy of the empiric formulas obtained with the 11 best predictions were evaluated with Bland-Altman plots. Subjects covered all the spectrum of SI between 0.19 and 21.3 min-1/(microU.mL-1)x10(-4). Eight procedures yielded satisfactory predictions of minimal model SI: (1) SI (from Matsuda's composite index)=-1.24+65/(IbGbImGm)-0.5; (2) SI=1.89+2690/(IbGbImGm); (3) SI (from Bennett's index)=-2.93+5.16/(log Ibxlog Gb); (4) SI (from Sluiter's index)=0.2+2400/(IpGp); (5) SI=-8.54+38.4/(Belfiore's ISI index); (6) SI (from Cederholm's formula)=76/(Gm log Im); (7) SI=0.248+0.947/GbIm; (8) SI (from Mari's "oral glucose insulin sensitivity" index)=oral glucose insulin sensitivity/Ip; (9) Caumo's model. Glucose effectiveness Sg can also be accurately predicted by the following formula: Sg=2.921e-0.185(G60- Gb) (Ip=insulin peak; Gp=glucose peak; Ia=insulin area; Ga=glucose area; G60=glycemia at 60 minutes). The hyperglucidic SBT can provide accurate evaluations of SI and Sg, either by elaborated models or by simple empiric formulas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631446     DOI: 10.1016/j.metabol.2006.01.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Assessing the predictive accuracy of oral glucose effectiveness index using a calibration model.

Authors:  Michael Glicksman; Shivraj Grewal; Shrayus Sortur; Brent S Abel; Sungyoung Auh; Trudy R Gaillard; Kwame Osei; Ranganath Muniyappa
Journal:  Endocrine       Date:  2018-11-06       Impact factor: 3.633

2.  Pilot study of resveratrol in older adults with impaired glucose tolerance.

Authors:  Jill P Crandall; Valerie Oram; Georgeta Trandafirescu; Migdalia Reid; Preeti Kishore; Meredith Hawkins; Hillel W Cohen; Nir Barzilai
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

3.  Methods for quantifying adipose tissue insulin resistance in overweight/obese humans.

Authors:  K W Ter Horst; K A van Galen; P W Gilijamse; A V Hartstra; P F de Groot; F M van der Valk; M T Ackermans; M Nieuwdorp; J A Romijn; M J Serlie
Journal:  Int J Obes (Lond)       Date:  2017-05-03       Impact factor: 5.095

4.  Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults.

Authors:  Rena M Pollack; Nir Barzilai; Valentin Anghel; Ameya S Kulkarni; Aaron Golden; Pilib O'Broin; David A Sinclair; Michael S Bonkowski; Alexander J Coleville; Danielle Powell; Sharon Kim; Ruin Moaddel; Daniel Stein; Kehao Zhang; Meredith Hawkins; Jill P Crandall
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-11-09       Impact factor: 6.053

5.  Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance.

Authors:  Po-Ju Lin; Katarina T Borer
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

6.  Fasting Glucose State Determines Metabolic Response to Supplementation with Insoluble Cereal Fibre: A Secondary Analysis of the Optimal Fibre Trial (OptiFiT).

Authors:  Stefan Kabisch; Nina M T Meyer; Caroline Honsek; Christiana Gerbracht; Ulrike Dambeck; Margrit Kemper; Martin A Osterhoff; Andreas L Birkenfeld; Ayman M Arafat; Mads F Hjorth; Martin O Weickert; Andreas F H Pfeiffer
Journal:  Nutrients       Date:  2019-10-06       Impact factor: 5.717

7.  Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?

Authors:  Candice Trocmé; Nicolas Gonnet; Margaux Di Tommaso; Hanen Samouda; Jean-Luc Cracowski; Claire Cracowski; Stéphanie Lambert-Porcheron; Martine Laville; Estelle Nobécourt; Chiraz Gaddhab; Allan Le Lay; Torsten Bohn; Christine Poitou; Karine Clément; Fahd Al-Mulla; Milad S Bitar; Serge P Bottari
Journal:  Front Mol Biosci       Date:  2021-02-16

8.  Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.

Authors:  Kevin C Maki; James M McKenney; Mildred V Farmer; Matthew S Reeves; Mary R Dicklin
Journal:  Nutr J       Date:  2009-05-28       Impact factor: 3.271

9.  Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT).

Authors:  Stefan Kabisch; Nina Marie Tosca Meyer; Caroline Honsek; Christiana Gerbracht; Ulrike Dambeck; Margrit Kemper; Martin A Osterhoff; Andreas L Birkenfeld; Ayman M Arafat; Martin O Weickert; Andreas F H Pfeiffer
Journal:  Nutrients       Date:  2019-11-11       Impact factor: 5.717

10.  Timing of Meals and Exercise Affects Hormonal Control of Glucoregulation, Insulin Resistance, Substrate Metabolism, and Gastrointestinal Hormones, but Has Little Effect on Appetite in Postmenopausal Women.

Authors:  Katarina T Borer; Po-Ju Lin; Elizabeth Wuorinen
Journal:  Nutrients       Date:  2021-12-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.